Hepatic Metastases in Gastrointestinal Cancer
- 1 April 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 116 (4) , 399-401
- https://doi.org/10.1001/archsurg.1981.01380160017004
Abstract
• The results of biochemical estimations in 116 patients with known gastrointestinal cancer but no clinically detectable metastatic hepatic disease have been analyzed statistically. The most sensitive and the most specific tests for the presence or absence of hepatic metastasis were measurements of alkaline phosphatase and γ-glutamyl transpeptidase. The predictive value for the absence of hepatic metastasis when the test results were normal was about 90% for alkaline phosphatase, γ-glutamyl transpeptidase, lactate dehydrogenase, and serum aspartate aminotransferase. The best predictive value for the presence of hepatic metastasis (80%) was given by abnormal results of combined estimations of γ-glutamyl transpeptidase and lactate dehydrogenase, and of γ-glutamyl transpeptidase and serum aspartate aminotransferase. (Arch Surg 1981;116:399-401)This publication has 5 references indexed in Scilit:
- HepatectomyPublished by Qeios Ltd ,2020
- Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic TestsNew England Journal of Medicine, 1978
- XXXI. On the sensitivity, specificity, and discrimination of diagnostic testsClinical Pharmacology & Therapeutics, 1975
- Diagnostic Accuracy of Hepatic Metastases at Laparotomy IUArchives of Surgery, 1956